Featured Projects

ACORN'HAI

Explore the ACORN-HAI study, a regional surveillance registry that tracks hospital-acquired infections to build evidence for future clinical trials and strengthen research collaboration across sites globally.

ACTIV3

Find out how SCRI supported Singapore's COVID-19 treatment research by swiftly activating clinical trials and enrolling patients within weeks of engagement.

AMN Network

Find out how the Asian Myeloma Network is advancing myeloma treatment for Asian patients through clinical trials, supported by SCRI's research expertise.

CEA PsyEdu

Find out how a web-based postnatal programme helps first-time mothers in Singapore gain confidence in newborn care and emotional well-being.

CPPL–DSO–2018

Find out how cryopreserved platelets could help address shortages in platelet supply, and how this landmark clinical study achieved its goals ahead of schedule.

EMPOWER

Find out how the EMPOWER study is improving end-of-life care for dying patients in Singapore's emergency departments through a structured, multi-phase research approach.

MUC–1

SCRI served as Study Sponsor for the MUC-1 First-in-Human clinical trial, overseeing safety, compliance, and regulatory submissions. Results are promising, with findings being prepared for publication.

NIH20–0006

Singapore's participation in the ACTT clinical trial helped fast-track access to COVID-19 treatments. Learn how SCRI supported the rapid launch and expansion of this global trial across six local hospitals.

PRIBIVAC

Find out how the PRIBIVAC trial is studying the best COVID-19 booster strategies, comparing different vaccine combinations to guide future vaccination programmes.

S–CATCH

Explore how a novel treatment based on endogenous apolipoprotein is being tested for acute brain bleeds. The S-CATCH study assesses its safety and potential efficacy in patients with supratentorial ICH.